Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: Absence of mutation among Asians and Pacific islanders

International Journal of Infectious Diseases

Volumn 3, Issue 4, 1999, Pages 186-191

  Lu, Yuanan ^a,i   Nerurkar, Vivek R ^a   Dashwood, Wan Mohaiza ^a   Woodward, Cora L ^a   Ablan, Sherimay ^a   Shikuma, Cecilia M ^a   Grandinetti, Andrew ^a   Chang, Healani ^a   Nguyen, Hien Tran ^b   Wu, Zunyou ^c   Yamamura, Yasuhiro ^d   Boto, William O ^e   Merriwether, Andrew ^f   Kurata, Takeshi ^g   Detels, Roger ^h   Yanagihara, Richard ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d PONCE SCHOOL OF MEDICINE   (Puerto Rico)

^e CITY UNIVERSITY OF NEW YORK   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Leahi Hospital   (United States)

Author keywords

Chemokine receptor; Human immunodeficiency virus; Melanesia; Micronesia; Polymerase chain reaction; Polynesia; Population genetics

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; ASIAN; BASE PAIRING; CAUCASIAN; DISEASE COURSE; ETHNIC GROUP; FEMALE; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC RESISTANCE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEGRO; PACIFIC ISLANDS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; VIRUS RESISTANCE;

EID: 6544295265     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(99)90022-X     Document Type: Article

References (25)

1. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872-877.
2. Deng HK, Unutmaz D, KewalRamani VN, Littman DR. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381:661-666.
3. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996; 85:1149-1158.
4. Alkahatib G, Cambadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1, MIP-1 receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272:1955-1958.
5. Dragic T, Litmin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381:667-673.
6. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85:1135-1148.
7. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 1996; 273:1856-1862.
8. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of CCR-5 chemokine receptor gene. Nature 1996; 382:722-725.
9. Huang Y, Paxton WA, Wolinsky SM, et al. The role of mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2:1240-1243.
10. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367-377.
11. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997; 3:338-340.
12. Zimmerman PA, Buckler-White A, Alkhatib G, et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med Ed 1997; 3:23-26
13. Misrahi M, Teglas JP, N'Go N, et al. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. JAMA 1998; 279:277-280.
14. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-base pair deletion. Nat Genet 1997; 16:100-103.
15. Li C, Yan YP, Shieh B, Lee CM, Lin RY, Chen YM. Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan. J Formos Med Assoc 1997; 96:969-984.
16. Nerurkar VR, Nguyen HT, Woodward CL, et al. Sequence and phylogenetic analyses of HIV-1 infection in Vietnam: subtype E in commercial sex workers and injection drug users. Cell Mol Biol 1997; 43:959-968.
17. Biti R, French R, Young J, Bennetts B, Stewan G. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med 1997; 3:352-353.
18. O'Brien TR, Winkler C, Dean M, et al. HIV-1 infection in a man homozygous for CCR532. Lancet 1997; 349:1219.
19. Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C. HIV-1 infection in an individual homozygous for CCR532. Lancet 1997; 349:1212-1213.
20. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997; 277:959-965.
21. Martin MP, Dean M, Smith MW, et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998; 282:1907-1911.
22. Kostrikis LG, Martinson JJ. Global distribution and origin of the CCR2-64I/CCR5-59653-T HIV disease-protective haplotype. 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, January 31-February 4, 1999.
23. Quillent C, Oberlin E, Braun J, et al. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 1998; 351:14-18.
24. Zagury D, Lachgar A, Chains V, et al. C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci U S A 1998; 95:3857-3861.
25. Su B, Chakrabarty R, Jin L, Xiao J, Lu D. An HIV-resistant allele is exceptionally frequent in New Guinean highlanders. JAMA 1998; 280:1830.